| scholarly article | Q13442814 |
| P50 | author | Dana Huskens | Q87666335 |
| Lisa N van der Vorm | Q89821661 | ||
| P2093 | author name string | Li Li | |
| Philip G de Groot | |||
| Mark Roest | |||
| Bas de Laat | |||
| Hilde Kelchtermans | |||
| Jasper A Remijn | |||
| Walid Chayouâ | |||
| P2860 | cites work | Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain | Q24304907 |
| Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor | Q24317407 | ||
| Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura | Q24651320 | ||
| The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. | Q30499388 | ||
| Influence of ABO blood groups on primary hemostasis | Q31846248 | ||
| von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation | Q33329307 | ||
| Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb). | Q53113539 | ||
| Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. | Q55283293 | ||
| Effects of Repeated Bouts of Exercise on the Hemostatic System | Q56986048 | ||
| von Willebrand factor and von Willebrand disease | Q68187358 | ||
| Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study | Q72653454 | ||
| Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma | Q81041403 | ||
| Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis | Q82279339 | ||
| Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients | Q83478461 | ||
| Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin | Q85257082 | ||
| Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome | Q87156161 | ||
| A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. | Q33367248 | ||
| Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome | Q33372621 | ||
| The presence of active von Willebrand factor under various pathological conditions | Q33374822 | ||
| beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation | Q33375186 | ||
| Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria | Q33375855 | ||
| The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission. | Q33385105 | ||
| Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13 | Q33401086 | ||
| Higher and lower active circulating VWF levels: different facets of von Willebrand disease | Q33426606 | ||
| Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow | Q33498992 | ||
| Diagnosis of platelet-type von Willebrand disease by flow cytometry | Q33886251 | ||
| von Willebrand factor, Jedi knight of the bloodstream | Q34106824 | ||
| Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. | Q34196324 | ||
| Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). | Q34528381 | ||
| Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort | Q35029443 | ||
| Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease | Q36369902 | ||
| Increased active von Willebrand factor during disease development in the aging diabetic patient population | Q36528288 | ||
| Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts | Q37490540 | ||
| von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends | Q38364984 | ||
| A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor | Q42524319 | ||
| Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study. | Q45865145 | ||
| Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. | Q46708842 | ||
| Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry | Q46868799 | ||
| Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test. | Q48123631 | ||
| Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect | Q48236513 | ||
| Advances in the diagnosis and treatment of Von Willebrand disease. | Q49989077 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ELISEA | Q332126 |
| P304 | page(s) | e0211961 | |
| P577 | publication date | 2019-02-13 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor | |
| P478 | volume | 14 |
| Q92138551 | A Hypoxic Environment Attenuates Exercise-Induced Procoagulant Changes Due to Decreased Platelet Activation |
| Q89821662 | Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease |
| Q91589588 | Implant stability in patients treated with platelet-rich fibrin and bovine bone substitute for alveolar ridge preservation is associated with peripheral blood cells and coagulation factors |
Search more.